CA Patent

CA2905438A1 — Agonists of guanylate cyclase and their uses

Assigned to Synergy Pharmaceuticals Inc · Expires 2014-09-25 · 12y expired

What this patent protects

This invention provides novel guanylate cyclase C (GC-C) agonists and their therapeutic use. The agonists may be used either alone or in combination with one or more additional agents.

USPTO Abstract

This invention provides novel guanylate cyclase C (GC-C) agonists and their therapeutic use. The agonists may be used either alone or in combination with one or more additional agents.

Drugs covered by this patent

Patent Metadata

Patent number
CA2905438A1
Jurisdiction
CA
Classification
—
Expires
2014-09-25
Drug substance claim
No
Drug product claim
No
Assignee
Synergy Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.